Anxiety and Substance Use: The Cycle That Keeps People Stuck
Anxiety and substance use feed each other in a loop that is hard to break from either side. Substances quiet anxiety briefly, then rebound symptoms drive the next use. Nearly 60% of adults with both conditions get no care for either, and understanding the cycle is the first step to treating both.

A loop, not a line
Anxiety and substance use are among the most common co-occurring conditions, and they trap people in a self-reinforcing loop. Anxiety makes a drink or a pill feel like relief. The relief is real but brief. As the substance wears off, anxiety rebounds, often worse than before, which drives the next use. Round and round.
This is not a rare pairing. In 2024, an estimated 21.2 million U.S. adults had both a mental illness and a substance use disorder in the past year. Among that group, 41.2% received neither mental health nor substance use treatment, and only 14.5% received both. Another 41.0% received mental health treatment only, and just 3.2% received substance use treatment only. Preliminary 2025 data suggest some improvement, with an estimated 18.5 million adults having both an SUD and a mental illness, and 57.4% receiving at least one type of treatment. Progress, but still nearly half getting nothing.
These figures cover mental illness broadly, not anxiety alone, but they show how often the two conditions travel together and how often care addresses only a piece of the problem. Separately, 7.4% of U.S. adults had moderate or severe symptoms of generalized anxiety disorder in 2024, and among adolescents ages 12 to 17, that figure was 18.8%, nearly one in five.
Why treating one is not enough
Someone who gets sober but never addresses the underlying anxiety is left white-knuckling through the exact feelings they were using to escape. Someone who treats the anxiety but keeps using never gives the treatment a stable foundation, because many substances worsen anxiety over time. Break only one side of the loop and the other pulls the person back.
The National Institute on Drug Abuse identifies anxiety disorders as among the mental health conditions that frequently occur alongside substance use disorders, and recommends screening people entering treatment for one condition for the other as a matter of routine care, not an afterthought.
What the cycle looks like day to day
- Reaching for a substance specifically to calm nerves, sleep, or face a situation.
- Rising anxiety, irritability, or panic as the substance leaves the system.
- Growing avoidance of situations without the substance available.
- A creeping sense that you cannot cope without it.
Part of what keeps this loop turning is that withdrawal and rebound symptoms can look a lot like anxiety itself: agitation, panic-like sensations, insomnia, sweating, tremor, and irritability. A clinician has to sort out whether someone has a primary anxiety disorder, a substance-induced set of symptoms, or both, and that distinction should never be made based only on how a person looks during intoxication or acute withdrawal. It takes a real evaluation over time.
What a thorough evaluation covers
A proper assessment for someone facing both concerns typically looks at:
- Anxiety symptoms, panic, trauma history, depression, suicidal thoughts, and sleep quality.
- Use of alcohol, nicotine, cannabis, opioids, stimulants, sedatives, and prescription medications.
- Timing: which symptoms came first, and how anxiety shifts during intoxication, right after use, or during withdrawal.
- Any history of dangerous withdrawal, including seizures, delirium, severe vomiting, or suicidal behavior.
- Current medications, medical conditions, housing stability, transportation, family support, and what the person actually wants out of treatment.
- Immediate safety risks: overdose, impaired driving, violence, self-harm, or an inability to meet basic daily needs.
Treating both at once
Integrated care treats the anxiety and the substance use as the connected problem they are. SAMHSA notes that treatment for co-occurring conditions may include medications, psychotherapy, rehabilitation, and support groups, matched to the person rather than applied as a single fixed protocol.
In practice, that usually combines several pieces:
- Evidence-based therapy for anxiety. Cognitive behavioral therapy is the most established approach, along with exposure-based treatment where appropriate, panic-focused therapy, and trauma-focused therapy when trauma is part of the picture.
- Medication decisions made carefully. Any medication for anxiety needs to account for the person's diagnosis, substance use history, other medical conditions, drug interactions, and overdose risk. That decision should never be based on a single symptom in isolation.
- Medications for the substance use disorder itself, where appropriate, such as FDA-approved options for opioid use disorder or alcohol use disorder. Treating the SUD directly often reduces the intoxication- and withdrawal-related anxiety that was feeding the cycle in the first place.
- Practical coping skills like paced breathing, grounding techniques, consistent sleep habits, and identifying personal triggers. These help with day-to-day distress but they support the clinical treatment rather than replace it.
- Recovery supports, including peer support, family involvement with the person's consent, mutual-help groups, and help with housing or transportation barriers that make treatment harder to sustain.
The American Society of Addiction Medicine's Fourth Edition criteria describe co-occurring mental health conditions as an expected part of addiction treatment, not an exception, and call for programs to be equipped to address them together using a holistic, person-centered approach.
Choosing the right level of care
The right setting depends on clinical need, not just on having a dual diagnosis on paper.
Outpatient care works when anxiety and substance use can be managed safely while someone continues living at home and attends regular therapy and medication appointments. Intensive outpatient or partial hospitalization offers more structure and more frequent contact while still allowing the person to stay in the community. Residential treatment provides a substance-free living environment and more intensive support when relapse risk, housing instability, or limited support make outpatient treatment unsafe or ineffective. Medically monitored withdrawal management may be necessary when withdrawal itself could be dangerous, particularly with heavy alcohol or benzodiazepine use, which can produce seizures or delirium and should never be stopped abruptly without medical guidance.
Opioid withdrawal is generally not medically dangerous on its own, but it carries a serious overdose risk once tolerance has dropped, especially if someone returns to a dose they used before a period of abstinence.
A note on safety
Combining alcohol with opioids, benzodiazepines, or other sedatives raises the risk of slowed breathing and fatal overdose. Anxiety, insomnia, or agitation during withdrawal should be reported to a clinician rather than managed by taking extra unprescribed medication. Anyone prescribed opioids, or at risk of exposure to them, should ask about naloxone and overdose response training. Seek urgent help for slowed or stopped breathing, blue or gray lips, seizures, severe confusion, chest pain, hallucinations, or thoughts of suicide.
For a mental health or substance use crisis, call or text 988. For a suspected opioid overdose, call 911, give naloxone if it is available, and stay with the person.
Getting past the access gap
Even with the will to get help, access remains a real obstacle. SAMHSA's 2024 data found that 80% of people who needed substance use treatment did not receive it. When evaluating a program, it helps to ask directly whether it offers integrated treatment for anxiety and substance use together, what its assessment and withdrawal risk process looks like, which levels of care it provides, and whether psychiatric medication management, therapy, and family services are all included under one roof.
Under the federal Mental Health Parity and Addiction Equity Act, health plans that cover mental health or substance use services generally cannot apply more restrictive limits than they apply to comparable medical or surgical care. Actual coverage still depends on the specific plan, so a plan's member services line is the most reliable source for what is covered.
The way out of the loop
The way out is not more willpower applied at one point on the circle. It is treating both sides until the loop no longer has anything to run on. East Point Behavioral Health treats anxiety and co-occurring substance use together for exactly this reason, with an assessment that looks at the whole picture rather than one condition at a time.
If this sounds like your situation or a loved one's, the next step is a conversation with a program that can assess both conditions at once. That single call can be the first turn away from the cycle instead of another lap around it.
Keep reading
Recognizing Depression Beneath Addiction
Depression often hides under addiction, and addiction often hides under depression. In 2024, 21.2 million U.S. adults had both a mental illness and a substance use disorder, and 41.2% got no treatment for either. Telling the two apart, and treating both together, changes the odds of recovery.
What Is Dual Diagnosis? Why Addiction and Mental Health Have to Be Treated Together
When addiction and a mental health condition occur together, treating one while ignoring the other rarely holds. Dual diagnosis care treats both at once. Here is what that means, why it works, and what to look for in a program.
Guidance by Your Role: Why the Family Member You Are Changes What You Need
A parent, a spouse, and a sibling are all hurt by the same addiction, but they carry different burdens, face different decisions, and need different support. Research on family-focused approaches like CRAFT shows why guidance matched to your specific role works better than generic advice aimed at "the family" as a whole.
What "Clearinghouse-Agnostic" Billing Actually Buys You
Behavioral health billing is not general medical billing with different codes. The payer mix is messier, the authorizations are constant, and the systems are often locked to one clearinghouse. Being clearinghouse-agnostic sounds like plumbing. It is actually leverage, and new CMS prior-authorization rules make that leverage more valuable every year.
Behavioral Health Updates is an independent industry publication published by vProGo.



